Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
Background Higher fibroblast growth factor‐23 (FGF‐23) levels are associated with incident heart failure (HF) in MESA (the Multiethnic Study of Atherosclerosis). FGF‐23 is also associated with left ventricular hypertrophy. Whether the FGF‐23 association with HF is similar for heart failure with redu...
Saved in:
| Main Authors: | Mohamed Faher Almahmoud, Elsayed Z. Soliman, Alain G. Bertoni, Bryan Kestenbaum, Ronit Katz, João A. C. Lima, Pamela Ouyang, P. Elliott Miller, Erin D. Michos, David M. Herrington |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-09-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.117.008334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocardial remodeling and fibroblast growth factor in patients with resistant hypertension
by: M. S. Litvinova, et al.
Published: (2022-12-01) -
Comparison of the effects of metformin and empagliflozin on cardiac function in heart failure with preserved ejection fraction mice
by: Xiehong Liu, et al.
Published: (2025-04-01) -
Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: A 3-year follow-up study
by: Ying Wang, et al.
Published: (2025-02-01) -
Single-cell RNA-seq uncovers lineage-specific regulatory alterations of fibroblasts and endothelial cells in ligamentum flavum hypertrophy
by: Yongxin Chen, et al.
Published: (2025-05-01) -
CDX1 improves nicotine induced cardiac fibroblasts activation and cardiomyocyte hypertrophy by alleviating autophagic flux impairment through modulation of LAPTM4B
by: Yue-yan Li, et al.
Published: (2025-03-01)